Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
Two immunotherapy drugs could be better than one - at least for a subset of ... The trial, run by scientists from the Dana-Farber Cancer Institute and ...
A late-breaking research poster being presented today provides the first evidence that Imprime PGG may have utility as a cancer vaccine platform.
Biothera's Imprime PGG Cancer Immunotherapy Drug Candidate Shows Potential to Enhance ... - Business Wire (press release)
New Data Demonstrate Potential of Biothera's Investigational Cancer Immunotherapy to Re-Orient ... -Business Wire (press release)
Biothera's Imprime PGG Investigational Immunotherapy Drug Modulates the Function of ... - Business Wire (press release)
CAR-T uses human T-cells as therapeutics to recognize and kill cancer ... Developers of immunotherapy treatments have been a hot sector for initial ...
Tumor-specific immunotherapy holds the promise of eradicating malignant tumors with exquisite precision without additional toxicity to standard ...
One of the hot new cancer immunotherapy drugs strongly benefited patients with melanoma, lung cancer and mesothelioma, according to three ...
CAMBRIDGE — Novartis AG, one of the world's leading cancer drug ... Calif.,immunotherapy company with three drug candidates in clinical trials.
The Journal for ImmunoTherapy of Cancer paper is titled, "Survival with ... and cancer immunotherapy—from basic research to clinical application.
Argos Therapeutics (ARGS) Announces Publication of AGS-003 Phase 2 Data as mRCC Treatment -StreetInsider.com
Dr.Stepher Hodi, director at the Melanoma Center, Dana Farber Cancer Institute said that the response rates and depth of response were pretty ...
Day 3 was a big news day at the AACR annual meeting. Today we learned the results of two high-profile clinical trials—in melanoma and triple ...
Cancer immunotherapy has conventionally relied on cell-mediated immunity while successful infectious disease vaccines have been shown to induce ...
New research on honokiol in bladder cancer was presented at the American Association for Cancer Research (AACR) Annual Meeting 2015.
Tumor PD-L1 expression has been observed at varying levels across many tumor types, including breast, lung and bladder cancer. Unnaturally high ...
Science Daily Cancer News
While dietary supplements may be advertised to promote health, new research shows a link between consumption of over-the-counter supplements and increased cancer risk, if the supplements are taken in excess of the recommended dietary amount. [This may be me! I have taken high doses of vitamins for years, believing these helped ward off cancer. They didn’t]
Childhood cancer survivors are five times more likely to have enrolled in a Social Security disability assistance program than other citizens, a new American study concludes. "The long-term impact of cancer can affect other issues besides health outcomes," said the lead author on the study. "We need to do a better job of helping people function throughout their lives, not just when they're finishing their cancer therapy."
Most cancer patients would opt for tumor profiling even if the test revealed that they or their families were at risk for other genetic diseases, according to a study. The study showed that despite the risk for receiving information about other potentially serious health problems, 59% of the cancer patients would agree to tumor profiling if offered by their physician. In a scenario where tumor profiling was already ordered, 79% of patients stated they wanted to know all of the information obtained.
Researchers have devised a way to re-engineer lupus antibodies to turn them into potential cancer killers. Lupus is a chronic inflammatory disease that occurs when the immune system attacks its own organs, tissues, or joints.
Men with prostate cancer benefit from treatment with the pioneering drug olaparib -- the first cancer drug to target inherited mutations -- according to the results of a major trial.
Developing technology is on track to predict if and when breast cancer will appear. "We're creating a breast cancer risk analysis system," said an electrical engineer on the study. "It will be able to inform doctors about the patient's risk of developing cancer within a few years."
While genetics play a substantial role in development of neuroblastoma, scientists say that something else is in play that elevates the risk: stress. Researchers have shown in mice genetically predisposed to develop neuroblastoma that maternal stress can push onset of the cancer.
Coffee helps to protect against breast cancer, a number of research studies have shown. A new study is added to that research, confirming that coffee inhibits the growth of tumors and reduces the risk of recurrence in women who have been diagnosed with breast cancer and treated with the drug tamoxifen.
A new study by immunology researchers sheds light on a mechanism affecting AID, a crucial enzyme for the immune response. The scientific breakthrough could eventually improve the way we treat the common flu, as well as lymphoma and leukemia, the researchers say.
Tambahkan Komentar